Peter A. Smith
YOU?
Author Swipe
View article: P052: Durable fracture rate reduction in patients with OI with setrusumab treatment: 14-month data from phase 2 of the Orbit study
P052: Durable fracture rate reduction in patients with OI with setrusumab treatment: 14-month data from phase 2 of the Orbit study Open
View article: Evaluation of Radiolucent Lesions in Cortices of Long Bones in Osteogenesis Imperfecta Patients
Evaluation of Radiolucent Lesions in Cortices of Long Bones in Osteogenesis Imperfecta Patients Open
(1)Radiolucent lesions are a characteristic finding of OI and have not been yet described in literature.(2)These lesions may represent a probable failure of ossification and lack of remodeling in the area of the lesion.(3)There is no clear…
View article: 6820 Assessing The Efficacy And Safety Of Setrusumab For Osteogenesis Imperfecta: Updated Phase 2 Data From The Phase 2/3 Orbit Study
6820 Assessing The Efficacy And Safety Of Setrusumab For Osteogenesis Imperfecta: Updated Phase 2 Data From The Phase 2/3 Orbit Study Open
Disclosure: G.S. Gottesman: Advisory Board Member; Self; Ultragenyx, Kyowa Kirin, Inc. Consulting Fee; Self; Ultragenyx. Research Investigator; Self; Alexion Pharmaceuticals, Inc., Ultragenyx. T.O. Carpenter: Advisory Board Member; Self; U…
View article: Psychosocial Outcomes of Pain and Pain Management in Adults with Osteogenesis Imperfecta: A Qualitative Study
Psychosocial Outcomes of Pain and Pain Management in Adults with Osteogenesis Imperfecta: A Qualitative Study Open
View article: A multicenter study to evaluate pain characteristics in osteogenesis imperfecta
A multicenter study to evaluate pain characteristics in osteogenesis imperfecta Open
The objective was to describe pain characteristics and treatments used in individuals with varying severity of osteogenesis imperfecta (OI) and investigate pain‐associated variables. This work was derived from a multicenter, longitudinal, …
View article: What are the long-term outcomes of lateral column lengthening for pes planovalgus in cerebral palsy?
What are the long-term outcomes of lateral column lengthening for pes planovalgus in cerebral palsy? Open
View article: Evidence Favors Ponseti Management of Clubfoot: Commentary on an article by James A.F. Recordon, MBCHB, et al.: "A Prospective, Median 15-Year Comparison of Ponseti Casting and Surgical Treatment of Clubfoot".
Evidence Favors Ponseti Management of Clubfoot: Commentary on an article by James A.F. Recordon, MBCHB, et al.: "A Prospective, Median 15-Year Comparison of Ponseti Casting and Surgical Treatment of Clubfoot". Open
View article: The sniff test
The sniff test Open
Courtroom testimony about dogs detecting dead bodies keeps sending people to prison—even without physical evidence. Critics say the science is lacking
View article: Osteogenesis imperfecta tooth level phenotype analysis: Cross-sectional study
Osteogenesis imperfecta tooth level phenotype analysis: Cross-sectional study Open
View article: Correction to: Do Bisphosphonates Alleviate Pain in Children? A Systematic Review
Correction to: Do Bisphosphonates Alleviate Pain in Children? A Systematic Review Open
View article: Malocclusion traits and oral health–related quality of life in children with osteogenesis imperfecta
Malocclusion traits and oral health–related quality of life in children with osteogenesis imperfecta Open
View article: A Multicenter Study of Intramedullary Rodding in Osteogenesis Imperfecta
A Multicenter Study of Intramedullary Rodding in Osteogenesis Imperfecta Open
Background: Osteogenesis imperfecta (OI), a heritable connective tissue disorder with wide clinical variability, predisposes to recurrent fractures and bone deformity. Management requires a multidisciplinary approach in which intramedullar…
View article: Hearing loss in individuals with osteogenesis imperfecta in North America: Results from a multicenter study
Hearing loss in individuals with osteogenesis imperfecta in North America: Results from a multicenter study Open
Hearing loss (HL) is an extra‐skeletal manifestation of the connective tissue disorder osteogenesis imperfecta (OI). Systematic evaluation of the prevalence and characteristics of HL in COL1A1/COL1A2‐related OI will contribute to a better …
View article: Pediatric Outcomes Data Collection Instrument is a Useful Patient-Reported Outcome Measure for Physical Function in Children with Osteogenesis Imperfecta
Pediatric Outcomes Data Collection Instrument is a Useful Patient-Reported Outcome Measure for Physical Function in Children with Osteogenesis Imperfecta Open
View article: Effect of Bisphosphonates on Function and Mobility Among Children With Osteogenesis Imperfecta: A Systematic Review
Effect of Bisphosphonates on Function and Mobility Among Children With Osteogenesis Imperfecta: A Systematic Review Open
Osteogenesis imperfecta (OI) is a rare genetic connective tissue disorder that results in bone fragility and deformity. Management is multi‐disciplinary. Although pharmacologic intervention with bisphosphonates (BP) is a standard of care f…
View article: Mobility in osteogenesis imperfecta: a multicenter North American study
Mobility in osteogenesis imperfecta: a multicenter North American study Open
View article: Oro-dental and cranio-facial characteristics of osteogenesis imperfecta type V
Oro-dental and cranio-facial characteristics of osteogenesis imperfecta type V Open
View article: A Multicenter Observational Cohort Study to Evaluate the Effects of Bisphosphonate Exposure on Bone Mineral Density and Other Health Outcomes in Osteogenesis Imperfecta
A Multicenter Observational Cohort Study to Evaluate the Effects of Bisphosphonate Exposure on Bone Mineral Density and Other Health Outcomes in Osteogenesis Imperfecta Open
Osteogenesis imperfecta (OI) is characterized by low bone mass and bone fragility. Using data from a large cohort of individuals with OI from the Osteogenesis Imperfecta Foundation's linked clinical research centers, we examined the associ…
View article: Dental and facial characteristics of osteogenesis imperfecta type V
Dental and facial characteristics of osteogenesis imperfecta type V Open
Osteogenesis imperfecta (OI) type V is an ultrarare heritable bone disorder caused by the heterozygous c.-14C>T mutation in IFITM5 . The dental and craniofacial phenotype has not been described in detail. In the present multicenter study (…
View article: Mobility in Osteogenesis Imperfecta: A Multicenter North American Study
Mobility in Osteogenesis Imperfecta: A Multicenter North American Study Open
Background Osteogenesis imperfecta (OI) is a genetic connective tissue disorder characterized by increased bone fragility and recurrent fractures. The phenotypic severity of OI has a significant influence on the ability to walk but little …
View article: Growth characteristics in individuals with osteogenesis imperfecta in North America: results from a multicenter study
Growth characteristics in individuals with osteogenesis imperfecta in North America: results from a multicenter study Open
View article: Macroscopic anisotropic bone material properties in children with severe osteogenesis imperfecta
Macroscopic anisotropic bone material properties in children with severe osteogenesis imperfecta Open
View article: Limb lengthening in pediatric patients with ollier's disease
Limb lengthening in pediatric patients with ollier's disease Open
Background: Ollier's disease is a non-hereditary skeletal disorder. Orthopedic management of limb length discrepancy could be complex given the nature of bone pathology, the significant amount of length discrepancy and the difficulty to pr…
View article: Non-Lethal Type VIII Osteogenesis Imperfecta Has Elevated Bone Matrix Mineralization
Non-Lethal Type VIII Osteogenesis Imperfecta Has Elevated Bone Matrix Mineralization Open
Context: Type VIII osteogenesis imperfecta (OI; OMIM 601915) is a recessive form of lethal or severe OI caused by null mutations in P3H1, which encodes prolyl 3-hydroxylase 1. Objectives: Clinical and bone material description of non-letha…
View article: Walker Design for Kinetic Assessment of Upper Extremity Joint Demands in Children with Osteogenesis Imperfecta
Walker Design for Kinetic Assessment of Upper Extremity Joint Demands in Children with Osteogenesis Imperfecta Open
View article: Role of Micro-CT in the Visualization, Measurement, and Quantification of Bone Structure in Osteogenesis Imperfecta
Role of Micro-CT in the Visualization, Measurement, and Quantification of Bone Structure in Osteogenesis Imperfecta Open
View article: Finite Element Modeling and Analysis Applications in Osteogenesis Imperfecta
Finite Element Modeling and Analysis Applications in Osteogenesis Imperfecta Open
Understanding the biomechanics of bones in persons with osteogenesis imperfecta (OI) is a key component to further understanding the disease, optimizing treatment and quality of life, as well as injury prevention. However, it is not feasib…
View article: Material and Structural Aspects of Bone in Osteogenesis Imperfecta
Material and Structural Aspects of Bone in Osteogenesis Imperfecta Open
Bone fragility is a fundamental problem in individuals with osteogenesis imperfecta (OI). The mechanisms behind this fragility, however, are not yet well understood. Multiple factors appear to contribute to the increased fracture risk in O…
View article: Upper Extremity Inverse Dynamics Model for Loftstrand Crutch-Assisted Gait in Children with Osteogenesis Imperfecta
Upper Extremity Inverse Dynamics Model for Loftstrand Crutch-Assisted Gait in Children with Osteogenesis Imperfecta Open
View article: Quantitative Assessment of Children with Osteogenesis Imperfecta
Quantitative Assessment of Children with Osteogenesis Imperfecta Open
Assessments of children with Osteogenesis Imperfecta (OI) are typically limited to a physical exam and observations from a clinician during a hospital visit. Often quantitative information such as bone mineral density and outcome questionn…